Rohan Palekar - 08 Sep 2022 Form 4 Insider Report for 89bio, Inc. (ETNB)

Role: Chief Executive Officer, Director
Signature: /s/ Ryan A. Murr, as attorney-in-fact for Rohan Palekar
Issuer symbol: ETNB
Transactions as of: 08 Sep 2022
Net transactions value: +$193,000
Form type: 4
Filing time: 09 Sep 2022, 16:39:18 UTC
Previous filing: 16 May 2022
Next filing: 30 Sep 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ETNB	Common Stock	Options Exercise	$193,000	+100,000	+102%	$1.93^*	197,623	08 Sep 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ETNB	Stock Option (Right to Buy)	Options Exercise	$0	-100,000	-31%	$0.000000	225,231	08 Sep 2022	Common Stock	100,000	$1.93	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Includes an aggregate of 1,666 shares acquired by the Reporting Person under the Issuer's 2019 Employee Stock Purchase Plan on June 30, 2022.
F2	This option is vested in full.